Ads
related to: alternative therapy for multiple sclerosis disease progression chart free- Starting Treatment
Download These Resources To
Help Your Patients Get Started.
- Dosing & Administration
Discover Dosing Information
For This Treatment.
- Patient Support Services
See Information On Our
Patient Support Program.
- Discover Efficacy Data
Explore Clinical Trial And
Efficacy Data.
- Safety And Vaccine Data
See Data On Long-Term
Safety And Tolerability.
- Patient Profiles
See If This Treatment May
Be Right For Your RMS Patients.
- Starting Treatment
Search results
Results From The WOW.Com Content Network
In March 2017, ocrelizumab was approved in the United States for the treatment of primary progressive multiple sclerosis in adults. [22] [42] It is also used for the treatment of relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. [42]
The Kurtzke Expanded Disability Status Scale (EDSS) is a method of quantifying disability in multiple sclerosis. [1] [2] The scale has been developed by John F. Kurtzke. [1] The EDSS is based on a neurological examination by a clinician. However, a number of versions have been developed which enable patient self-administration. [3]
Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by Merck Serono and Pfizer in the US under an exception to the Orphan Drug Act.
Multiple sclerosis. Multiple sclerosis is an autoimmune disease, primarily mediated by T-cells. [15] The three main characteristics of MS are the formation of lesions in the central nervous system (also called plaques), inflammation, and the destruction of myelin sheaths of neurons.
Alemtuzumab, sold under the brand names Campath and Lemtrada among others, is a medication used to treat chronic lymphocytic leukemia and multiple sclerosis. [8] In chronic lymphocytic leukemia, it has been used as both a first line and second line treatment. [8] It is given by injection into a vein. [8]
The Swank Diet is a diet that is low in saturated fat, which was proposed in 1949 by Roy Laver Swank, MD, PhD (1909–2008), academic neurologist at the University of Oregon, for the treatment of multiple sclerosis. [1] The claims made for the diet are unsubstantiated. [1] [2]
Ads
related to: alternative therapy for multiple sclerosis disease progression chart free